Oscar Health faces challenges amid market downturn
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 30 2024
0mins
Should l Buy OSCR?
Source: Coinmarketcap
Oscar Health Inc. saw its stock price decline as it hit a 5-day low, reflecting broader market weakness with the Nasdaq-100 down 1.44% and the S&P 500 down 1.20%.
Despite Oscar Health's impressive growth in insurance membership, which surged to 3.4 million in 2025, the company is facing challenges from expiring subsidies that could impact its future performance. Additionally, while the company projects revenue growth from $11.7 billion in 2025 to as high as $19 billion in 2026, the current market conditions are affecting investor sentiment.
The implications of these developments suggest that while Oscar Health has a strong growth trajectory, the current market environment may pose risks to its stock performance, particularly as it navigates potential headwinds from subsidy expirations.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 13.300
Low
11.00
Averages
15.75
High
25.00
Current: 13.300
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Recent Earnings Reports from CrowdStrike and Wix
- Mispriced Stocks: The video discusses three stocks considered mispriced, potentially offering buying opportunities for investors, especially in the context of market volatility, necessitating careful risk and reward assessment.
- CrowdStrike Earnings Highlights: CrowdStrike's recent earnings report indicates strong revenue growth, although specific figures are not disclosed, its leadership in cybersecurity may attract more investor attention, driving stock price increases.
- Wix Performance: Wix's latest earnings report is also noteworthy; while specific financial data is not provided, its ongoing growth in website building and online services underscores the company's significance in digital transformation, potentially impacting its future market performance.
- Market Reaction Analysis: The video was published on March 10, 2026, with trading data from March 9, prompting investors to monitor stock price fluctuations of CrowdStrike and Wix to assess the earnings reports' impact on market sentiment.
See More
Analysis of Three Mispriced Stocks and Earnings Reports
- Earnings Reports: Recent earnings reports from CrowdStrike and Wix indicate their competitive positioning in the market, although specific figures were not disclosed, analysts believe both companies have growth potential ahead.
- Investment Recommendations: The Motley Fool's analyst team identified 10 stocks for investors, notably excluding Meta Platforms, suggesting a cautious outlook on Meta's future, which could impact its stock performance.
- Historical Returns Comparison: The Motley Fool Stock Advisor boasts an average return of 952%, significantly outperforming the S&P 500's 191%, indicating that its recommended stocks have excelled in long-term investments, providing a reference for investors.
- Market Dynamics: The video mentions a
See More
Trump's State of the Union Influences Market Sentiment
- Market Sentiment Shift: Investors are digesting President Trump's State of the Union address, leading to a slight market sentiment improvement, with Nasdaq and Russell 2000 futures up 0.1%, while S&P 500 and Dow futures remain flat, reflecting anticipation for Nvidia's upcoming earnings report.
- Nvidia Export Controls: U.S. officials confirmed that Nvidia has not yet sold its flagship H200 chips to China, despite recent export approvals, raising market concerns about future sales and potential spillover effects on competitors like AMD and Intel.
- M&A Tensions: Warner Bros. Discovery stated that Paramount Global's revised $31 billion acquisition bid may be superior to its existing deal with Netflix, intensifying market focus on media sector mergers and potentially impacting the stock performance of involved companies.
- Healthcare Policy Changes: Trump announced plans to end Affordable Care Act premium tax credits during his address, redirecting funds to consumers instead of large insurance companies, which could have significant implications for the healthcare insurance industry, particularly for firms like UnitedHealth.
See More
Health Insurance Stocks Face Challenges and Opportunities
- Market Share Growth: Oscar Health's insurance membership surged to 3.4 million in 2025 from just 400,000 at the end of 2020, showcasing its competitive edge in the individual health insurance market despite risks from expiring subsidies.
- Revenue Recovery Outlook: Oscar Health projects its revenue to rise from $11.7 billion in 2025 to as high as $19 billion in 2026, with operating earnings expected between $250 million and $450 million, indicating strong performance in price increases and customer retention.
- Legacy Insurer Rebound: UnitedHealth Group anticipates generating $439 billion in revenue and $24 billion in operating earnings in 2026, despite facing challenges like cybersecurity incidents and antitrust lawsuits, highlighting its robust market position and profitability.
- Valuation Appeal: With a current market cap of $260 billion, UnitedHealth trades at just over 10 times its operating income, suggesting that, given rising healthcare inflation and an aging population, the stock may be undervalued and present a solid investment opportunity in the coming years.
See More
Oscar Health Stock Gains: Key Insights
- Earnings Report: Oscar Health reported a quarterly loss of $1.24 per share, which was wider than the expected $0.89 loss and a significant decline from last year's $0.62 loss; however, revenue grew 17% year-over-year to $2.81 billion, albeit below the consensus of $3.12 billion.
- Guidance Outlook: The company provided a revenue guidance for 2026 of $18.7 billion to $19.0 billion, significantly exceeding Wall Street's estimate of $12.565 billion, indicating strong growth potential, while expecting a medical loss ratio between 82.4% and 83.4% and operating earnings between $250 million and $450 million.
- Upgrade Impact: Raymond James anticipates Oscar will achieve approximately 2% EBIT margin in 2026, increasing to around 4% in 2027 due to improvements in medical loss ratio and operational efficiencies, with much of the uncertainty regarding ACA subsidies already reflected in the stock price.
- Stock Movement: As of Thursday, Oscar Health shares rose by 0.96% to $13.73, reflecting market confidence in the company's growth potential despite the disappointing short-term earnings report, while the long-term EPS target remains at $2.25, indicating investor optimism about future performance.
See More
Major Wall Street Rating Updates
- Apple Siri Upgrade Delay: Evercore ISI reiterates Apple as outperform, suggesting that reports of delays in Siri upgrades are overstated, with expectations for a multi-phase rollout of AI features this year, emphasizing the importance of privacy protection and seamless integration.
- Shopify Attractiveness Upgrade: TD Cowen upgrades Shopify from hold to buy, citing its strong quarterly performance and continued growth momentum as compelling reasons for investors to consider the stock, especially given its recent price decline.
- Fastly's Stellar Performance: William Blair upgrades Fastly from market perform to outperform following impressive earnings, driven by a significant increase in AI traffic contributions, indicating substantial growth potential in this emerging sector.
- MercadoLibre's Improved Competitive Landscape: JPMorgan upgrades MercadoLibre from neutral to overweight, noting a reduction in competitive pressures in the Latin American online marketplace, with expectations for sustained growth in the coming quarters.
See More
Analysis of Recent Earnings Reports from CrowdStrike and Wix
- Mispriced Stocks: The video discusses three stocks considered mispriced, potentially offering buying opportunities for investors, especially in the context of market volatility, necessitating careful risk and reward assessment.
- CrowdStrike Earnings Highlights: CrowdStrike's recent earnings report indicates strong revenue growth, although specific figures are not disclosed, its leadership in cybersecurity may attract more investor attention, driving stock price increases.
- Wix Performance: Wix's latest earnings report is also noteworthy; while specific financial data is not provided, its ongoing growth in website building and online services underscores the company's significance in digital transformation, potentially impacting its future market performance.
- Market Reaction Analysis: The video was published on March 10, 2026, with trading data from March 9, prompting investors to monitor stock price fluctuations of CrowdStrike and Wix to assess the earnings reports' impact on market sentiment.
See More
Analysis of Three Mispriced Stocks and Earnings Reports
- Earnings Reports: Recent earnings reports from CrowdStrike and Wix indicate their competitive positioning in the market, although specific figures were not disclosed, analysts believe both companies have growth potential ahead.
- Investment Recommendations: The Motley Fool's analyst team identified 10 stocks for investors, notably excluding Meta Platforms, suggesting a cautious outlook on Meta's future, which could impact its stock performance.
- Historical Returns Comparison: The Motley Fool Stock Advisor boasts an average return of 952%, significantly outperforming the S&P 500's 191%, indicating that its recommended stocks have excelled in long-term investments, providing a reference for investors.
- Market Dynamics: The video mentions a
See More
Trump's State of the Union Influences Market Sentiment
- Market Sentiment Shift: Investors are digesting President Trump's State of the Union address, leading to a slight market sentiment improvement, with Nasdaq and Russell 2000 futures up 0.1%, while S&P 500 and Dow futures remain flat, reflecting anticipation for Nvidia's upcoming earnings report.
- Nvidia Export Controls: U.S. officials confirmed that Nvidia has not yet sold its flagship H200 chips to China, despite recent export approvals, raising market concerns about future sales and potential spillover effects on competitors like AMD and Intel.
- M&A Tensions: Warner Bros. Discovery stated that Paramount Global's revised $31 billion acquisition bid may be superior to its existing deal with Netflix, intensifying market focus on media sector mergers and potentially impacting the stock performance of involved companies.
- Healthcare Policy Changes: Trump announced plans to end Affordable Care Act premium tax credits during his address, redirecting funds to consumers instead of large insurance companies, which could have significant implications for the healthcare insurance industry, particularly for firms like UnitedHealth.
See More
Health Insurance Stocks Face Challenges and Opportunities
- Market Share Growth: Oscar Health's insurance membership surged to 3.4 million in 2025 from just 400,000 at the end of 2020, showcasing its competitive edge in the individual health insurance market despite risks from expiring subsidies.
- Revenue Recovery Outlook: Oscar Health projects its revenue to rise from $11.7 billion in 2025 to as high as $19 billion in 2026, with operating earnings expected between $250 million and $450 million, indicating strong performance in price increases and customer retention.
- Legacy Insurer Rebound: UnitedHealth Group anticipates generating $439 billion in revenue and $24 billion in operating earnings in 2026, despite facing challenges like cybersecurity incidents and antitrust lawsuits, highlighting its robust market position and profitability.
- Valuation Appeal: With a current market cap of $260 billion, UnitedHealth trades at just over 10 times its operating income, suggesting that, given rising healthcare inflation and an aging population, the stock may be undervalued and present a solid investment opportunity in the coming years.
See More
Oscar Health Stock Gains: Key Insights
- Earnings Report: Oscar Health reported a quarterly loss of $1.24 per share, which was wider than the expected $0.89 loss and a significant decline from last year's $0.62 loss; however, revenue grew 17% year-over-year to $2.81 billion, albeit below the consensus of $3.12 billion.
- Guidance Outlook: The company provided a revenue guidance for 2026 of $18.7 billion to $19.0 billion, significantly exceeding Wall Street's estimate of $12.565 billion, indicating strong growth potential, while expecting a medical loss ratio between 82.4% and 83.4% and operating earnings between $250 million and $450 million.
- Upgrade Impact: Raymond James anticipates Oscar will achieve approximately 2% EBIT margin in 2026, increasing to around 4% in 2027 due to improvements in medical loss ratio and operational efficiencies, with much of the uncertainty regarding ACA subsidies already reflected in the stock price.
- Stock Movement: As of Thursday, Oscar Health shares rose by 0.96% to $13.73, reflecting market confidence in the company's growth potential despite the disappointing short-term earnings report, while the long-term EPS target remains at $2.25, indicating investor optimism about future performance.
See More
Major Wall Street Rating Updates
- Apple Siri Upgrade Delay: Evercore ISI reiterates Apple as outperform, suggesting that reports of delays in Siri upgrades are overstated, with expectations for a multi-phase rollout of AI features this year, emphasizing the importance of privacy protection and seamless integration.
- Shopify Attractiveness Upgrade: TD Cowen upgrades Shopify from hold to buy, citing its strong quarterly performance and continued growth momentum as compelling reasons for investors to consider the stock, especially given its recent price decline.
- Fastly's Stellar Performance: William Blair upgrades Fastly from market perform to outperform following impressive earnings, driven by a significant increase in AI traffic contributions, indicating substantial growth potential in this emerging sector.
- MercadoLibre's Improved Competitive Landscape: JPMorgan upgrades MercadoLibre from neutral to overweight, noting a reduction in competitive pressures in the Latin American online marketplace, with expectations for sustained growth in the coming quarters.
See More
